|1.||Yi, Shou-Pu: 1 article (01/2015)|
|2.||Su, Rui-Bin: 1 article (01/2015)|
|3.||Jia, Yan-Xing: 1 article (01/2015)|
|4.||Wang, Mei-Liang: 1 article (01/2015)|
|5.||Wang, Zhi-Tong: 1 article (01/2015)|
|6.||Huang, Bin: 1 article (01/2015)|
|7.||Yu, Gang: 1 article (01/2015)|
|8.||Gong, Ze-Hui: 1 article (01/2015)|
|9.||Zhang, Feng-Ying: 1 article (01/2015)|
|10.||Chi, Yu-Ming: 1 article (09/2005)|
|1.||Neuralgia (Stump Neuralgia)
01/01/2015 - "Using a series of animal models, this study further evaluated the effects of incarvillateine against acute, inflammatory, and neuropathic pain. "
01/01/2015 - "These results indicate that incarvillateine is a novel analgesic compound that is effective against inflammatory and neuropathic pain, and that its effects are associated with activation of the adenosine system. "
03/01/2001 - "Incarvillateine (1), a new monoterpene alkaloid carrying a characteristic cyclobutane ring, has been found to show significant antinociceptive activity in a formalin-induced pain model in mice. "
09/01/2005 - "The activities of alpha-truxillic acid (1) and 4,4'-dihydroxy-alpha-truxillic acid (2) at the dose of 40 mg/kg against inflammatory pain response were equal to that of incarvillateine at doses of 20 mg/kg."
01/01/2015 - "Moreover, incarvillateine-induced antinociception was attenuated by theophylline, 1,3-dipropyl-8-cyclopentylxanthine, and 3,7-dimethyl-1-propargylxanthine, but not naloxone, indicating that the effects of incarvillateine on chronic pain were related to the adenosine system, but not opioid system. "
01/01/2015 - "Additionally, incarvillateine attenuated mechanical allodynia induced by spared nerve injury or paclitaxel, whereas normal mechanical sensation was not affected. "
01/01/2015 - "In a Complete Freund's Adjuvant model, incarvillateine inhibited both thermal hyperalgesia and paw edema, and increased interleukin-1β levels. "